Quick Answer
Organon & Co. reported Total Revenue of $6.22 billion for the year ending 2025.
- Organon & Co. showed a decrease of -2.9% in Total Revenue from 2024 to 2025.
- This data is from Organon & Co.'s annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2020: $1.78 billion | Q2 2020: $1.53 billion | Q3 2020: $1.61 billion | Q1 2021: $1.51 billion | Q2 2021: $1.60 billion | Q3 2021: $1.60 billion | Q1 2022: $1.57 billion | Q2 2022: $1.59 billion | Q3 2022: $1.54 billion | Q1 2023: $1.54 billion | Q2 2023: $1.61 billion | Q3 2023: $1.52 billion | Q1 2024: $1.62 billion | Q2 2024: $1.61 billion | Q3 2024: $1.58 billion | Q1 2025: $1.51 billion | Q2 2025: $1.59 billion | Q3 2025: $1.60 billion.
- Over the full 7 years of available data (2019 to 2025), Organon & Co.'s Total Revenue has declined by 20.1%.
- Historical annual values: Fiscal year 2025: $6.22 billion | Fiscal year 2024: $6.40 billion | Fiscal year 2023: $6.26 billion | Fiscal year 2022: $6.17 billion | Fiscal year 2021: $6.30 billion | Fiscal year 2020: $6.53 billion | Fiscal year 2019: $7.78 billion.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: